| Literature DB >> 31043989 |
Piotr P Buszman1,2, Bartlomiej Orlik1, Krzysztof P Milewski1, Tomasz Roleder3, Michał Jelonek1, Filip Polczyk4, Frank D Kolodgie5, Maciej Jankowski6, Renu Virmani5, Paweł E Buszman1,3.
Abstract
INTRODUCTION: Preclinical, vascular response studies are limited due to lack of underlying disease. The available cholesterol-diet-based and genetic atherosclerotic models are not satisfactory due to long breeding, unpredictable lesion formation, low plaque volume and degree of stenosis. AIM: To evaluate the vascular response to local, intramural delivery of human, highly atherogenic lipids into healthy domestic swine (DS) coronary arteries.Entities:
Keywords: animal model of atherosclerosis; in-stent restenosis; local delivery; swine
Year: 2019 PMID: 31043989 PMCID: PMC6488843 DOI: 10.5114/aic.2019.83774
Source DB: PubMed Journal: Postepy Kardiol Interwencyjnej ISSN: 1734-9338 Impact factor: 1.426
Figure 1Intramural injection of studied solutions utilizing modified circumferential, triple needle delivery catheter (Peregrine, ASI)
Figure 2Study flow chart
Quantitative coronary angiography at baseline and follow-up
| Parameter | POBA ( | LDL ( | 0.9% NaCl ( | |
|---|---|---|---|---|
| Baseline: | ||||
| Minimal lumen diameter [mm] | 2.48 ±0.3 | 2.42 ±0.2 | 2.61 ±0.4 | 0.46 |
| Vessel reference diameter [mm] | 2.67 ±0.4 | 2.58 ±0.2 | 2.77 ±0.3 | 0.48 |
| Balloon diameter [mm] | 3.17 ±0.2 | 3.10 ±0.2 | 3.30 ±0.2 | 0.30 |
| Balloon-to-artery ratio | 1.29 ±0.2 | 1.30 ±0.2 | 1.22 ±0.2 | 0.68 |
| Follow-up: | ||||
| Minimal lumen diameter [mm] | 2.35 ±0.4 | 2.36 ±0.4 | 2.48 ±0.3 | 0.77 |
| Vessel reference diameter [mm] | 2.53 ±0.4 | 2.61 ±0.5 | 2.75 ±0.2 | 0.55 |
| Percent area stenosis (%) | 14.45 ±6.6 | 18.11 ±6.5 | 18.57 ±11.0 | 0.58 |
| Percent diameter stenosis (%) | 7.36 ±3.6 | 9.57 ±3.6 | 9.96 ±6.5 | 0.53 |
| Late lumen loss [mm] | 0.13 ±0.4 | 0.29 ±0.9 | 0.12 ±0.4 | 0.82 |
Intravascular ultrasound (IVUS) volumetric, planimetric and near-infra red spectroscopy analysis (NIRS). Optical coherence tomography (OCT) volumetric and planimetric parameters
| Parameter | POBA ( | LDL ( | 0.9% NaCl ( | |
|---|---|---|---|---|
| Optical coherence tomography: | ||||
| Minimal lumen area [mm2] | 5.54 ±1.1 | 4.31 ±2.4 | 6.66 ±2.7 | 0.15 |
| Minimal lumen diameter (average) | 2.61 ±0.3 | 2.26 ±0.7 | 2.86 ±0.7 | 0.17 |
| Lumen volume | 151.3 ±43 | 143 ±72 | 159 ±60 | 0.89 |
| Minimal lumen diameter | 2.34 ±0.2 | 1.98 ±0.6 | 2.60 ±0.7 | 0.13 |
| % Diameter stenosis | 12.35 ±11.9 | 35.97 ±20.8 | 16.42 ±13.2 | 0.02 |
| %AS (MLD based) | 8.13 ±7.8 | 23.67 ±13.7 | 10.80 ±8.7 | 0.02 |
| Lesion length | 20.95 ±4.2 | 21.84 ±4.3 | 18.60 ±1.8 | 0.34 |
| Intravascular ultrasound and NIRS: | ||||
| Lumen volume [mm3] | 180.6 ±101 | 165.6 ±71 | 198.2 ±60 | 0.72 |
| Lipid core burden index (LCBI, NIRS) | 2.8 ±7 | 0 | 0 | 0.35 |
| Minimal lumen plaque burden | 32.3 ±12 | 38.8 ±19 | 28.6 ±17 | 0.45 |
| Plaque area | 3.1 ±2 | 4.2 ±3 | 2.9 ±1 | 0.43 |
| Plaque volume NIRS’ | 55.6 ±45 | 68.5 ±41 | 45.0 ±11 | 0.46 |
| Lumen eccentricity NIRS’ | 0.1 | 0.1 | 0.1 | 0.19 |
Figure 3Morphometric lesion evaluation in optical coherence tomography
*P < 0.05 LDL vs. POBA and LDL vs. NaCl.
Figure 4Plaque composition in virtual histology IVUS
FI – fibrous tissue, FF – fibrofatty tissue, NC – necrotic core.
Figure 5Representative, corresponding images of vessel cross sections in pathology and multimodal intravascular imaging modalities. From left to right: pathology, OCT, NIRS with IVUS, VH-IVUS
Figure 6LDL injection – low (Movat pentachrome) and respective high power (H&E) stained sections show severe arterial balloon injury and restenosis consisting mainly of SMCs and proteoglycan matrix. There are isolated areas of lymphohistiocytic inflammation, including a few giant cells in the deep media, adventitia, and peri-adventitial space (blue arrows)
Pathological evaluation
| Parameter | POBA ( | LDL ( | 0.9% NaCl ( | ||||
|---|---|---|---|---|---|---|---|
| Median | 25–75 | Median | 25–75 | Median | 25–75 | ||
| Morphometry: | |||||||
| Lumen area | 1.00 | 0.7–1.3 | 0.81 | 0.6–1.1 | 0.91 | 0.5–1.5 | 0.57 |
| IEL area | 1.93 | 1.3–2.1 | 1.56 | 1.2–2.2 | 1.51 | 1.0–2.2 | 0.97 |
| Med area | 1.93 | 1.6–2.4 | 2.04 | 1.6–2.8 | 1.99 | 1.7–2.7 | 0.97 |
| EEL area | 3.87 | 2.8–4.6 | 3.72 | 3.0–5.0 | 3.92 | 2.8–5.1 | 0.97 |
| Neointimal area | 0.6 | 0.4–1.1 | 0.97 | 0.4–1.3 | 0.55 | 0.3–0.6 | 0.72 |
| Med Inj Score | 1.60 | 1.1–2.1 | 2.20 | 1.4–3.1 | 1.80 | 0.9–2.0 | 0.22 |
| % Stenosis | 17.20 | 11.7–24.0 | 33.0 | 14–45 | 19.0 | 4–24 | 0.14 |
| Qualitative analysis: | |||||||
| Free cholesterol | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
| Fibrin/thrombus | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
| Necrotic core | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
| Neo/fibrosis | 0.90 | 0.7–1.0 | 1.00 | 0.8–1.0 | 0.80 | 0.6–1.0 | 0.30 |
| Macrophage | 0.00 | 0.0–0.0 | 0.02 | 0.0–0.4 | 0.00 | 0.0–0.0 | 0.4 |
| T cells | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
| IPH | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
| Calcification | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | 0.00 | 0.0–0.0 | |
IEL – internal elastic lamina, Med. – medial layer area, EEL – external elastic lamina.